Larimar Therapeutics: Targeting the Root Cause of Friedreich’s Ataxia with Nomlabofusp
Biotech company poised to lead FA treatment with innovative protein replacement therapy Larimar Therapeutics (LRMR) has emerged as a promising ...
Tag: News
Coinbase Navigates Market Revival as Stablecoin Market Cap Surges
The crypto exchange raises estimates for Q3 2024 amid stablecoin market recovery and regulatory optimism The cryptocurrency landscape has undergone ...
Perspective Therapeutics Expands Radiopharmaceutical Production with New Facility in New Jersey
State-of-the-art facility supports advanced cancer treatment applications, accelerating product distribution Perspective Therapeutics (CATX), a leading radiopharmaceutical company, has announced the ...
AMD’s Growth Outlook: AI Prospects Rise, but Market Challenges Loom
Server Share Gains and AI Expansion Counterbalance Gaming and PC Sector Weakness Advanced Micro Devices (AMD) is set to announce ...
ASML Lowers 2025 Revenue Forecast Amid Semiconductor Industry Slowdown
Chinese Demand Declines as Semiconductor Equipment Giant Faces Market Uncertainty ASML (ASML), the Dutch semiconductor equipment manufacturer, has issued a ...
SoFi Strikes $2 Billion Deal with Fortress Investment to Expand Personal Loan Business
Strategic Partnership Marks a Major Step in Diversifying Revenue Sources SoFi Technologies (SOFI), an online bank with a vision of ...
Nvidia’s Stock Surges as Blackwell Chip Production Reignites Investor Confidence
AI Leadership and Strong Demand Drive Growth Projections Nvidia's (NVDA) stock is making a strong comeback, climbing 13% this month ...
Upstart Upgraded to Neutral as Improving Credit Quality and Lower Rates Drive Positive Outlook
Better Loan Performance and Diversified Funding Set the Stage for a Stronger 2H’24 Upstart Holdings (UPST), a company known for ...
Affirm Holdings Upgraded to Neutral as Lower Interest Rates Brighten Outlook
Reduced Funding Costs and GMV Growth to Bolster the Buy Now, Pay Later Pioneer Shares of Affirm Holdings (AFRM), a ...
CATX Showcases Breakthroughs in Radiopharmaceutical Development at Oppenheimer Summit
Targeted radiopharmaceuticals promising multiple catalysts and clinical advancements heading into 2024 CATX (CATX), a company pioneering targeted radiopharmaceutical therapies, provided ...
